rs1258184
Positions:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1
The NM_018245.3(OGDHL):c.564C>T(p.Leu188=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.478 in 1,613,382 control chromosomes in the GnomAD database, including 193,363 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.41 ( 14875 hom., cov: 32)
Exomes 𝑓: 0.48 ( 178488 hom. )
Consequence
OGDHL
NM_018245.3 synonymous
NM_018245.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.99
Genes affected
OGDHL (HGNC:25590): (oxoglutarate dehydrogenase L) The protein encoded by this gene is similar to oxoglutarate dehydrogenase (OGDH) of the OGDH complex, which degrades glucose and glutamate. This gene encodes several isoforms, including some that appear to localize to mitochondria. The encoded protein down-regulates the AKT signaling cascade and can suppress the growth of cervical cancer cells. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 10-49752163-G-A is Benign according to our data. Variant chr10-49752163-G-A is described in ClinVar as [Benign]. Clinvar id is 3059593.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-2.99 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.867 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OGDHL | NM_018245.3 | c.564C>T | p.Leu188= | synonymous_variant | 5/23 | ENST00000374103.9 | NP_060715.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OGDHL | ENST00000374103.9 | c.564C>T | p.Leu188= | synonymous_variant | 5/23 | 1 | NM_018245.3 | ENSP00000363216 | P1 | |
OGDHL | ENST00000419399.4 | c.393C>T | p.Leu131= | synonymous_variant | 4/22 | 2 | ENSP00000401356 | |||
OGDHL | ENST00000432695.2 | c.-64C>T | 5_prime_UTR_variant | 3/21 | 2 | ENSP00000390240 |
Frequencies
GnomAD3 genomes AF: 0.412 AC: 62596AN: 151936Hom.: 14876 Cov.: 32
GnomAD3 genomes
AF:
AC:
62596
AN:
151936
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.489 AC: 122670AN: 251048Hom.: 32572 AF XY: 0.483 AC XY: 65599AN XY: 135692
GnomAD3 exomes
AF:
AC:
122670
AN:
251048
Hom.:
AF XY:
AC XY:
65599
AN XY:
135692
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.485 AC: 708694AN: 1461328Hom.: 178488 Cov.: 47 AF XY: 0.481 AC XY: 350030AN XY: 726986
GnomAD4 exome
AF:
AC:
708694
AN:
1461328
Hom.:
Cov.:
47
AF XY:
AC XY:
350030
AN XY:
726986
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.412 AC: 62608AN: 152054Hom.: 14875 Cov.: 32 AF XY: 0.415 AC XY: 30858AN XY: 74330
GnomAD4 genome
AF:
AC:
62608
AN:
152054
Hom.:
Cov.:
32
AF XY:
AC XY:
30858
AN XY:
74330
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2224
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
OGDHL-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 11, 2021 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at